March 21, 2018 / 6:54 AM / a month ago

BRIEF-Theranexus ‍Announces Successful Study In Development Of THN201 And THN101​

March 21 (Reuters) - THERANEXUS SA:

* ‍ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below